Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Return on Capital Employed (2016 - 2026)

Phibro Animal Health has reported Return on Capital Employed over the past 12 years, most recently at 15.17% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 603.0% year-over-year to 15.17%; the TTM value through Dec 2025 reached 15.17%, up 603.0%, while the annual FY2025 figure was 12.58%, 568.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 15.17% at Phibro Animal Health, up from 13.06% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 15.17% in Q4 2025 and troughed at 6.87% in Q2 2024.
  • A 5-year average of 9.94% and a median of 9.68% in 2025 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: tumbled -295bps in 2023 and later soared 603bps in 2025.
  • Year by year, Return on Capital Employed stood at 11.27% in 2021, then decreased by -19bps to 9.09% in 2022, then dropped by -19bps to 7.34% in 2023, then grew by 25bps to 9.14% in 2024, then surged by 66bps to 15.17% in 2025.
  • Business Quant data shows Return on Capital Employed for PAHC at 15.17% in Q4 2025, 13.06% in Q3 2025, and 10.56% in Q2 2025.